To The Moon

$Morgan Stanley(MS)$ 試下，博業績，多謝🙏 投資涉及風險，價格可升可跌，做好風險管理。

$ASML 20260618 1200.0 CALL$ After exiting my previous short-term ASML call, the plan was always to re-enter. I closed that position following the initial gap-up a few days ago, but unfortunately missed the continuation move that followed. I took advantage of yesterday’s pullback to re-enter via another call option. This time, I’ve gone with a longer-dated contract (six months) and plan to hold at least through the upcoming earnings before reassessing the next move.

$Alphabet(GOOGL)$   Alphabet is a long term play.

$PLTR 20271217 280.0 PUT$  The far sell call decays abit daily 

$CRITICAL METALS CORPORATION(CRML)$ buy in trenches due to lesson learnt ... cash out @ high of $15.40

$CapLand IntCom T(C38U.SI)$ hoping for good results on Feb 6th!

$Direxion Daily Semiconductors Bull 3x Shares(SOXL)$ recurring investment. won't be fear!

$Tesla Motors(TSLA)$  Waiting for unsupervised robotaxi to be fully released be like... 🫩💀 Still holding long till mid year at the very least

$TSLA 20260116 420.0 PUT$ Was going to close this option earlier but ended up holding to expiry day this friday. Will close on any bad news that may come out.

$Intel(INTC)$   Saw an article and it plays right into Intel situation and playbook.  Catalyst: Recent news highlights that TSMC is hitting capacity limits for Nvidia and other major AI chipmakers — meaning supply bottlenecks. That constraint is reshaping the AI chip supply chain, creating space for alternative foundries. Intel’s Foundry Services could benefit as customers seek available, reliable capacity versus waiting on TSMC backlogs — calling it a potential “golden ticket” for Intel’s foundry comeback. 📊 Short Technical Analysis (Daily/Weekly View) Trend: • Price has broken past recent consolidation, holding above key horizontal support near prior congestion zones (mid-term pivot). • Stronger higher l

JPMorgan’s investment-banking (IB) miss is a useful caution signal, but it does not on its own prove a broad-based collapse in capital markets activity. 1) Does the miss imply a wider slowdown in capital markets? More “uneven recovery” than “broad slowdown”. JPM’s miss was product-specific and timing-driven. Reporting indicated the shortfall was materially tied to debt underwriting coming in below what the bank itself had guided, rather than a uniform decline across all capital-markets lines.  The wider industry backdrop is not signalling a freeze. Dealogic data cited by Reuters showed global investment banking revenue rose about 15% in 2025, with M&A volumes also materially higher year on year. That is inconsistent with a generalised capital-markets slump.  Trading strength

Missed Nvidia or SpaceX? The "Second Source" Strategy Could Be Your Next Alpha 🚀 Everyone loves a winner. In this market, the spotlight is permanently fixed on the kings: Nvidia ($NVDA) in AI, SpaceX in aerospace, and Tesla ($TSLA) in EVs. But here is a counter-intuitive truth that smart money knows: Sometimes, the "Second Best" offers a better risk/reward setup than the King. Why? Because in business and national security, reliance on a single supplier is suicide. When one company holds a 90% monopoly, the market (and the government) will pay a premium to keep the runner-up alive. This is the "Second Source" trade—and if you missed the rally on the leaders, this is where you should be looking. 1️⃣ The "Hostage" Dilemma: Why Big Tech Needs a Backup Imagine you are the procurement chief at

Look, I’ve been following this AI gold rush pretty closely, and right now it feels like we’re watching the most expensive bet in tech history play out in real time.The numbers are honestly insane. The biggest cloud players — think Amazon, Microsoft, Google, Meta — are burning through something like half a trillion dollars in capital expenditures over just two years. We’re talking new data centers popping up faster than anyone can count, insane power deals, custom chips, whole new grids being planned… it’s like the entire industry decided to build the next decade of computing all at once.And the question everyone (including me) keeps asking is:Okay… but how are they actually going to make that money back?Here’s what I’m seeing in early 2026 — the realistic ways companies are starting to tur

Hello everyone. Today, I'd like to use the Ctrip stock crash incident to discuss managing short put positions.What Happened:💡 Cause: On January 14th, based on China's Anti-Monopoly Law, the State Administration for Market Regulation formally launched an investigation into Ctrip for suspected abuse of market dominance.💡 Impact on Stock Price: Ctrip's US-listed stock (Ticker: TCOM) closed at $75.68 on January 13th and plummeted 17% to close at $62.78 on January 14th. Ctrip's Hong Kong-listed stock (Ticker: 09961) closed at HKD 569 on January 14th and fell sharply intraday, down 20% to HKD 452 on January 15th.💡 Impact on Business: Ctrip issued an announcement stating that all company operations are normal and that the investigation has not yet had a material impact on its business.Changes in

$Meta Platforms, Inc.(META)$   META’s $14B Nuclear Gamble: Is Mark Zuckerberg Building a Moat or a Money Pit? Meta Platforms (META) dropped 2.2% following reports that its new nuclear-powered data center could come with an eye-watering $14 billion price tag. This isn’t just a headline about a single factory; it’s a wake-up call regarding the true cost of the AI arms race. While Big Tech has been battling over GPUs (Nvidia chips), the battlefield has quietly shifted to the one thing chips can’t run without: Energy. But for traders, the immediate question is sharper: Does this massive CapEx spend signal a visionary long-term play, or are we seeing a return to the unchecked spending that crushed the stock in 2022? 1️⃣ The Sticker Shock: Why

$NVIDIA(NVDA)$ 🌏 Buckle up, tech enthusiasts! In a bold escalation amid the US-China tech showdown, Beijing has slammed the brakes on Nvidia's powerhouse H200 AI chips. Customs agents are outright blocking imports, and officials are warning domestic giants: don't buy unless it's absolutely critical – think university R&D labs only. This isn't just a speed bump; it's a full-on roadblock that could reshape the global AI landscape. 😲 🔍 Let's dive deep into the drama. Sources reveal Chinese authorities summoned top tech firms for urgent meetings, delivering a crystal-clear message: H200 purchases get the green light solely under "special circumstances." No explanations, no timelines – just a vague "necessary" clause that's leaving everyone scratch

$AMN Healthcare Services Inc(AMN)$ $Cross Country Healthcare(CCRN)$  $JPMorgan Chase(JPM)$  📈🏥🚀 $AMN Healthcare triggers a JPM-driven regime shift 🚀🏥📈 $AMN just ripped +19% after releasing its JPM Healthcare Conference deck, triggering a liquidity pocket breakout and a full institutional repricing across healthcare staffing, hospital services and defensive growth. This was not retail. This was fund flow, gamma reset and earnings regime change. 💰 Why Wall Street hit the buy button AMN is no longer being treated as a cyclical staffing name. It is now being repriced as a healthcare workforce infrastructure platform with pricing power, margin levera